- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00183456
A Peer-Oriented HIV Prevention Outreach Program for Individuals at High Risk for HIV and Other STIs
Network HIV Prevention Intervention for Drug Users
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The persistence of HIV and STD epidemics indicates that more effective, sustainable preventive interventions are needed, particularly for low-income, inner-city populations. This study will determine the effectiveness of a theoretically based peer outreach program in preventing HIV and STD transmission among adults in the Baltimore, Maryland area.
Participants will be randomly assigned to receive either a network-oriented peer program emphasizing one's social identity and the goals of protecting one's family and community or group cognitive behavioral therapy (CBT). The peer program will also train participants to provide HIV/STD education to their peers. Participants will be assessed at study entry and during several subsequent follow-up visits. At these study visits, participants will complete questionnaires about their sexual health knowledge and sexual behaviors. Participants and members of their peer network will have follow-up visits at Months 6, 12, and 18.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21231
- The Lighthouse
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria for CBT or Peer Intervention Participants:
- Female
- Age 18-55
- Did not inject drugs in the past 6 months
- Self-reported sex with at least 1 male partner in the past 6 months
Had at least 1 of the following sexual risk factors:
- More than 2 sex partners in the past 6 months
- STI diagnosis in the past 6 months
- Had a high risk sex partner in the past 90 days (i.e. a sex partner that injected drugs, smoked crack, was HIV+, or MSM)
Inclusion Criteria for Peer Network Participants:
- 18 years old or older
One of the following:
- Injected drugs
- Sex partner of index
- Social network member that the index felt comfortable talking to about HIV/STIs
Exclusion Criteria for All Participants:
- Currently enrolled in another HIV prevention intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Condition: CHAT
Participants received the program over the course of five small group sessions and one individual session based on a harm reduction philosophy.
Participants were trained as Peer Mentors and were encouraged to talk to their family, friends, and sex partners about a range of sex risk reduction options.
|
The peer-oriented intervention program emphasized social identity and the goals of protecting family and community.
The peer program also trained participants to provide HIV/STD education to their peers.
|
|
Active Comparator: Comparison Condition: Standard of Care
The comparison condition consisted of one group session.
The session focused on HIV and STIs transmission and risk reduction information.
|
Group CBT will focus on teaching ways to modify thoughts and behaviors associated with risky sexual behaviors.
|
|
No Intervention: Network Participants
Index participants generated a list of network members during their baseline visits and were asked to recruit eligible network members into the study.
These network participants completed study interviews but did not participate in the intervention.
|
|
|
No Intervention: Non-randomized Baseline index participants
This arm includes those index participants that did not show up for randomization or did not recruit a network member were thus not eligible to be randomized into a study condition.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sex Risk Behaviors: Number of Sex Partners (>=2 Sex Partners)
Time Frame: 6 months
|
Number of participants that had 2 or more sex partners in the past 90 days.
|
6 months
|
|
Sex Risk Behaviors: Unprotected Sex With Non-main Partner (Past 90 Days)
Time Frame: 12 months
|
12 months
|
|
|
Sex Risk Behaviors: Unprotected Anal Sex (Past 90 Days)
Time Frame: 18 month
|
18 month
|
|
|
Sex Risk Behaviors: Unprotected Vaginal Sex (Past 90 Days)
Time Frame: 18 months
|
18 months
|
|
|
Sex Risk Behaviors: Unprotected Sex With Main Partner (Past 90 Days)
Time Frame: 18 months
|
18 months
|
|
|
Sex Risk Behaviors: Unprotected Sex With a Non-main Partner (Past 90 Days)
Time Frame: 18 months
|
18 months
|
|
|
Sex Risk Behaviors: Any High Risk Sexual Behavior (Past 90 Days)
Time Frame: 18 months
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
HIV Communication: Talk to Family About HIV or STIs (Past 6 Months)
Time Frame: 6 months
|
6 months
|
|
HIV Communication: Talk to Family About HIV or STIs (Past 6 Months)
Time Frame: 12 months
|
12 months
|
|
HIV Communication: Talk to Family About HIV or STIs (Past 6 Months)
Time Frame: 18 months
|
18 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Carl A. Latkin, PhD, Johns Hopkins Bloomberg School of Public Health
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01MH066810 (U.S. NIH Grant/Contract)
- DAHBR 9A-ASI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.